Excimer Lasers

Subscribe to Selected New Research on Excimer Lasers

1245 relevant articles (136 outcomes, 134 trials/studies) found for this Therapy

Description: Gas lasers with excited dimers (i.e., excimers) as the active medium. The most commonly used are rare gas monohalides (e.g., argon fluoride, xenon chloride). Their principal emission wavelengths are in the ultraviolet range and depend on the monohalide used (e.g., 193 nm for ArF, 308 nm for Xe Cl). These lasers are operated in pulsed and Q-switched modes and used in photoablative decomposition involving actual removal of tissue. (UMDNS, 2005)

Also Known As:

Lasers, Excimer; ArF Excimer Lasers; ArF Lasers; Argon Fluoride Lasers; Excimer Laser; Excimer Lasers, ArF; Excimer Lasers, Argon Fluoride; Excimer Lasers, KrCl; Excimer Lasers, Krypton Chloride; Excimer Lasers, XeCl; Excimer Lasers, Xenon Chloride; KrCl Excimer Lasers; Krypton Chloride Lasers; Lasers, ArF Excimer; Lasers, Argon Fluoride Excimer; Lasers, KrCl; Lasers, Krypton Chloride; Lasers, Krypton Chloride Excimer; Lasers, XeCl Excimer; Lasers, Xenon Chloride; Lasers, Xenon Chloride Excimer; XeCl Lasers; Xenon Chloride Lasers; ArF Excimer Laser; ArF Laser; Argon Fluoride Laser; Chloride Laser, Krypton; Chloride Laser, Xenon; Chloride Lasers, Krypton; Chloride Lasers, Xenon; Excimer Laser, ArF; Excimer Laser, KrCl; Excimer Laser, XeCl; Fluoride Laser, Argon; Fluoride Lasers, Argon; KrCl Excimer Laser; KrCl Laser; KrCl Lasers; Krypton Chloride Laser; Laser, ArF; Laser, ArF Excimer; Laser, Argon Fluoride; Laser, Excimer; Laser, KrCl; Laser, KrCl Excimer; Laser, Krypton Chloride; Laser, XeCl; Laser, XeCl Excimer; Laser, Xenon Chloride; Lasers, ArF; Lasers, Argon Fluoride; Lasers, KrCl Excimer; Lasers, XeCl; XeCl Excimer Laser; XeCl Excimer Lasers; XeCl Laser; Xenon Chloride Laser; Argon Fluoride Excimer Lasers; Krypton Chloride Excimer Lasers; Xenon Chloride Excimer Lasers

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Nonionizing Radiation

Light

Lasers: 18967

Excimer Lasers: 1245

Experts

1.	Topaz, On: 7 articles (01/2008 - 04/2003)
2.	Taylor, Charles R: 6 articles (05/2004 - 05/2002)
3.	Tulleken, Cornelis A F: 5 articles (07/2008 - 10/2002)
4.	van der Zwan, Albert: 5 articles (07/2008 - 10/2002)
5.	Dahm, Johannes B: 5 articles (01/2008 - 03/2004)
6.	Ebersole, Douglas: 4 articles (01/2008 - 03/2004)
7.	Das, Tony: 4 articles (01/2008 - 03/2004)
8.	Vora, Kishor: 4 articles (01/2008 - 03/2004)
9.	Raulin, Christian: 4 articles (03/2006 - 01/2004)
10.	Greve, Bärbel: 4 articles (03/2006 - 01/2004)

Related Diseases

1.	Myopia 08/01/2006 - "CONCLUSIONS: Bilateral refractive lensectomy is effective for improving functional vision in neurobehaviorally impaired children who have high myopia (beyond the range of excimer laser correction: see companion publication) and difficulties wearing glasses" 01/01/1997 - "CONCLUSIONS: MLK is effective in high myopia treatment and has some special advantages compared with radial keratotomy, photorefractive keratectomy, automated lamellar keratoplasty and excimer laser in situ keratomileusis" 04/01/1995 - "CONCLUSIONS: Excimer laser photorefractive keratectomy is an alternative means of treating high and extreme myopia and can cause a significant reduction in myopia" 04/01/1995 - "We assessed the efficacy of excimer laser treatment for persons with high (spherical equivalent between -5 and -10 diopters) and extreme (spherical equivalent greater than -10D) myopia" 11/01/2000 - "CONCLUSION: PRK and LASIK with the Nidek EC-5000 excimer laser are effective and safe for correcting low to moderate myopia, but LASIK eyes showed better results for moderate myopia in terms of uncorrected visual acuity." Order ALL the reference details at left...
2.	Astigmatism 07/01/2000 - "One eye (1.7%) lost 2 or more lines of best spectacle-corrected visual acuity.CONCLUSION: Photoastigmatic refractive keratectomy with the Summit Apex Plus excimer laser is a safe and effective method of reducing compound myopic astigmatism" 05/01/1996 - "OBJECTIVE: To study the efficacy of excimer laser photorefractive keratectomy (PRK) for high, moderate, and low degrees of primary myopic astigmatism" 11/01/2004 - "The number of reoperations and residual refractive defects were significantly better in Group 2. CONCLUSION: The 2-step technique improved the accuracy of excimer laser correction of post-PKP astigmatism." 09/01/2002 - "CONCLUSIONS: Photorefractive keratectomy with the MEL-70 excimer laser to correct myopic astigmatism was a safe and effective procedure with good stability at six months' follow-up" 03/01/2000 - "CONCLUSIONS: The efficacy of LASIK after penetrating keratoplasty was good compared to incisional or surface based excimer laser methods and has the advantage of reducing the myopic spherical equivalent refraction in addition to astigmatism, thus improving the uncorrected visual acuities." Order ALL the reference details at left...
3.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2004 - "The most recent form of phototherapy, 308-nm excimer laser, holds promise for becoming a useful tool in the treatment of stable, localized psoriasis." 11/01/2007 - "Excimer laser treatment for psoriasis has been associated with good results at a lower cumulative dose than narrowband ultraviolet (UV)B protocols" 05/01/2002 - "CONCLUSION: As little as one high-dose excimer laser treatment can be effective for localized plaque-type psoriasis" 12/01/2007 - "CONCLUSION: Our clinical data suggest that treatment of psoriasis vulgaris by a 308 nm excimer laser is effective and safe, and it is more efficacious in macular type than in chronic plaque type." 08/01/2007 - "CONCLUSION: The possible explanations for the superior efficacy of the excimer laser over traditional UVB therapy for psoriasis include: 1) a higher intensity UV light to plaques, which is more effective in clearing psoriasis; 2) penetration into the dermis where it may induce T cell apoptosis, potentially to a greater extent than the wavelength or given energy level predicts; and 3) the difference in the delivery of UVB light may result in cell death and skin immune system suppression more effectively than traditional UVB." Order ALL the reference details at left...
4.	Vitiligo 10/01/2007 - "CONCLUSIONS: The 308-nm excimer laser is effective for therapy to treat vitiligo on the face and neck" 05/01/2005 - "CONCLUSIONS: 308-nm excimer laser therapy is effective against vitiligo" 03/01/2004 - "Narrow-band UVB therapy has been shown to be effective and safe for use in the management of vitiligo; its wavelength is not so different from 308 nm XeCl excimer laser radiation" 05/01/2006 - "BACKGROUND: The treatment with XeCl-excimer laser generated 308-nm UVB radiation has shown promising results in patients with vitiligo" 07/01/2004 - "BACKGROUND: Recent reports show that 308-nm excimer laser may be an effective and safe method for the treatment of vitiligo, which is usually resistant to other available treatment methods" Order ALL the reference details at left...
5.	Hyperopia (Hypermetropia) 11/01/1999 - "OBJECTIVE: To evaluate safety and efficacy of excimer laser in situ keratomileusis (LASIK) for high and moderate hyperopia" 11/01/1999 - "CONCLUSION: LASIK with the Keracor 117CT excimer laser appears to be an effective and safe procedure to correct hyperopia" 01/01/1998 - "CONCLUSION: Excimer laser keratomileusis in situ with the Keracor 116 appears to be an effective and safe procedure to decrease low and moderate hyperopia, but the predictability of the procedure needs improvement." 09/01/1998 - "BACKGROUND: This paper presents the results over a 2-year follow-up of the first human trial of photorefractive keratectomy (PRK) for correction of hyperopia using an erodible disc excimer laser delivery system (Summit) coupled to an axicon lens" 07/01/1997 - "PURPOSE: This paper presents the results of the first human trial on the correction of hyperopia using an erodible mask excimer laser delivery system coupled to an axicon" Order ALL the reference details at left...

Related Drugs and Biologics

1.	xenon chloride
2.	chiron
3.	Indomethacin (Indometacin)
4.	Diclofenac (SR 38)
5.	Hyaluronic Acid (Hyaluronan)
6.	Ophthalmic Solutions (Eye Drops)
7.	glucuronyl glucosamine glycan sulfate (Vessel)
8.	AT-308 (AT 308)
9.	Diamond
10.	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)

Related Therapies and Procedures

1.	Photorefractive Keratectomy
2.	Laser In Situ Keratomileusis (LASIK)
3.	Angioplasty (Angioplasties)
4.	Lasers (Laser)
5.	Penetrating Keratoplasty

Best Treatments:
Research Summary Report
on Myopia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 238 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>